Keyphrases
Fulminant Hepatic Failure
100%
Hepatic Encephalopathy
100%
Cyclooxygenase Inhibitors
100%
Cyclooxygenase-1 (COX-1)
83%
Cyclooxygenase-2
66%
Liver Biochemistry
50%
NS-398
50%
MRNA Expression
33%
Inducible Nitric Oxide Synthase
33%
Mortality Rate
33%
Tumor Necrosis Factor-α
33%
Prostaglandins
33%
Motor Activity
33%
No Significant Difference
16%
Keto
16%
Liver
16%
Aspartate Aminotransferase
16%
Factor Level
16%
Therapeutic Effect
16%
Biochemical Tests
16%
Distilled Water
16%
Cyclooxygenase-2 Inhibitors
16%
Plasma Parameters
16%
Thioacetamide
16%
Active Metabolite
16%
Histopathological Changes
16%
Prostacyclin
16%
Water Control
16%
Ammonia Level
16%
Aminotransferase Levels
16%
Liver Histopathology
16%
Cyclooxygenase-1/2
16%
Pharmacology, Toxicology and Pharmaceutical Science
Fulminant Hepatic Failure
100%
Prostaglandin Synthase
100%
Hepatic Encephalopathy
100%
Cyclooxygenase 2
66%
Cyclooxygenase 1
66%
NS-398
50%
Messenger RNA
50%
Nitric Oxide Synthase
33%
Tumor Necrosis Factor
33%
Mortality Rate
33%
Prostaglandin
33%
Aspartate Aminotransferase
16%
Therapeutic Effect
16%
COX-2 Inhibitor
16%
Thioacetamide
16%
Active Metabolite
16%
Prostacyclin
16%
Distilled Water
16%
Prostaglandin Synthase Inhibitor
16%
Cyclooxygenase 1 Inhibitor
16%
Biochemistry, Genetics and Molecular Biology
Cyclooxygenase
100%
Liver Biochemistry
23%
Messenger RNA
23%
NS-398
23%
Tumor Necrosis Factor
15%
Mortality Rate
15%
Motor Activity
15%
Nitric Oxide Synthase
15%
Prostaglandin
15%
Blood Level
7%
Metabolite
7%
Prostacyclin
7%
COX-2 Inhibitor
7%
Thioacetamide
7%
Ammonia Blood Level
7%
Aspartate Aminotransferase Level
7%